Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease

Abstract

Epstein-Barr virus (EBV), a ubiquitous human herpesvirus and an aetiological agent of infectious mononucleosis, has a unique trop-ism for B lymphocytes1. Clinical and laboratory features of chronic active EBV infections are chronic or persistent infectious mononu-cleosis-like symptoms and high antibody titre against early anti-gens (EA)2–4 . Kawasaki disease (KD), aetiology unknown, is thought to be self-limited immunologically mediated vasculitis. Clinical features of KD are fever, rash, mucositis, lym-phadenopathy and coronary artery damage5,6. We report here a child with chronic active EBV infection accompanied by dilatation of coronary arteries. All the EBV-determined nuclear antigen (EBNA)-positive lymphocytes had exclusively CD4 antigen, as revealed by dual staining immunofluorescence analysis. Southern blot hybridization showed that the purified CD4+ cells harboured EBV genome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Epstein, M. A. & Achong, B. G. The Epstein-Barr Virus (eds Epstein, M. A. & Achong, B. G.) 1–22 (Springer, Berlin, 1979).

    Google Scholar 

  2. Alfieri, C., Ghibu, F. & Joncus, J. H. Can. med. Assoc. J. 131, 1249–1252 (1984).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Jones, J. F. et al. Ann. Int. Med. 102, 1–7 (1985).

    Article  CAS  Google Scholar 

  4. Alfieri, C. & Joncas, J. H. J. Virol. 61, 3306–3309 (1987).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Kawasaki, T. et al. Pediatrics 54, 271–276 (1974).

    CAS  PubMed  Google Scholar 

  6. Fujiwara, H. & Hamashima, Y. Pediatrics 61, 100–107 (1978).

    CAS  PubMed  Google Scholar 

  7. Zimber, U. et al. Virology 154, 56–66 (1986).

    Article  CAS  Google Scholar 

  8. Reedman, B. M. & Klein, G. Int. J. Cancer 11, 499–520 (1973).

    Article  CAS  Google Scholar 

  9. Henle, W. et al. Science 169, 188–190 (1970).

    Article  ADS  CAS  Google Scholar 

  10. Henle, G. & Henle, W. J. Bacterial. 91, 1248–1256 (1966).

    CAS  Google Scholar 

  11. Salahuddin, B. Z. et al. Science 234, 596–601 (1986).

    Article  ADS  CAS  Google Scholar 

  12. Josephs, S. F. et al. Science 234, 601–603 (1986).

    Article  ADS  CAS  Google Scholar 

  13. Tanner, J., Weis, J., Fearon, D., Whang, Y. & Kieff, E. Cell 50, 203–213 (1987).

    Article  CAS  Google Scholar 

  14. Kikuta, H. et al. Pediatrics 73, 413–414 (1984).

    CAS  PubMed  Google Scholar 

  15. Iwanaga, M. et al. Lancet 1, 938–939 (1981).

    Article  CAS  Google Scholar 

  16. Kikuta, H. et al. Acta Paediatr. Jpn 28, 120 (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kikuta, H., Taguchi, Y., Tomizawa, K. et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333, 455–457 (1988). https://doi.org/10.1038/333455a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/333455a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing